TAKEDA HUMAN ALBUMIN 20% SOLUTION 100 ML

TAKEDA HUMAN ALBUMIN 20% SOLUTION 100 ML Injection is given intravenously through infusion, and the amount of the drug will be measured based on the patient's body weight, age, and health status.

It is not known whether TAKEDA HUMAN ALBUMIN 20% SOLUTION 100 ML Injection causes fetal harm or passes into the breast milk. However, telling your healthcare practitioner if you suspect pregnancy, breastfeeding, or planning to have a baby before starting this treatment is advisable.

It is important to know that you should not dilute albumin solution with sterile water as it may result in hemolysis and acute kidney injury.

People who are hypersensitive to TAKEDA HUMAN ALBUMIN 20% SOLUTION 100 ML or its ingredients should not use TAKEDA HUMAN ALBUMIN 20% SOLUTION 100 ML Injection. This drug is also not recommended for people with severe anemia, heart failure, and kidney problems.

Yes, you will be monitored during TAKEDA HUMAN ALBUMIN 20% SOLUTION 100 ML treatment. Your healthcare provider will regularly assess your blood pressure, heart rate, electrolytes, and complete blood count.

Information regarding the interaction of TAKEDA HUMAN ALBUMIN 20% SOLUTION 100 ML with other drugs should be discussed with your healthcare provider.

Maintaining proper hydration is important, both before and after TAKEDA HUMAN ALBUMIN 20% SOLUTION 100 ML infusion. If you notice any changes in your symptoms or have concerns about the treatment, immediately communicate them to your physician for more advice.

TAKEDA HUMAN ALBUMIN 20% SOLUTION 100 ML is made using Human Albumin.

TAKEDA HUMAN ALBUMIN 20% SOLUTION 100 ML is prescribed for conditions such as Kidney Disease and Heart Disorder.